This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

AI-driven muscle mass assessment could improve care for head and neck cancer patients

CT scan
Credit: Pixabay/CC0 Public Domain

Researchers from Dana-Farber Cancer Institute have found a way to use artificial intelligence (AI) to diagnose muscle wasting, called sarcopenia, in patients with head and neck cancer. AI provides a fast, automated, and accurate assessment that is too time-consuming and error-prone to be made by humans. The tool, published in JAMA Network Open, could be used by doctors to improve treatment and supportive care for patients.

"Sarcopenia is an indicator that the patient is not doing well. A real-time tool that tells us when a patient is losing would trigger us to intervene and do something supportive to help," says lead author Benjamin Kann, MD, a radiation oncologist in the Department of Radiation Oncology at Dana-Farber Brigham Cancer Center.

Head and neck cancers are typically treated with combinations of surgery, radiation, and chemotherapy. The treatments can be curative, but they also can have harsh side effects. Patients sometimes have trouble drinking and eating during and after treatment, leading to poor nutrition and sarcopenia.

Sarcopenia is associated with an increased chance of needing a , having a lower quality of life, and worse outcomes in general, including earlier death. "Muscle mass is a very important indicator of health," says Kann. "People with more mass are generally healthier and more robust."

Doctors can assess muscle mass by analyzing computed tomography (CT) scans of the abdomen or the neck. CT scans of the neck are common and frequent for with head and , giving doctors an opportunity to identify sarcopenia early and intervene.

But diagnosis of sarcopenia from a CT scan requires a highly trained expert to examine the scan and differentiate the muscle from other tissue. It is painstaking work and takes up to 10 minutes to complete. "The process is time-consuming and burdensome, so it's not done regularly," says Kann.

Kann and colleagues set out to use , a form of AI, to diagnose sarcopenia using CT scans of the neck. To train the AI model, they accessed clinical records and CT scans from 420 patients with head and neck cancer. An expert performed an assessment of muscle mass for each patient based on the CT scans and calculated a skeletal muscle index (SMI) score. The team used the resulting dataset to train the to make the same assessments.

"The AI model automatically delineates the muscle in the neck from other tissues," says Kann. "The results are transparent. You can see the outline of the muscle as assessed by AI and verify it with your own eyes."

The team used a second dataset containing similar data from a different patient group to validate the AI model's ability to diagnose sarcopenia. In this test, the model made clinically acceptable assessments of muscle mass 96.2% of the time based on a review by an expert panel. The AI model completes an assessment of a scan in approximately 0.15 seconds.

Currently, doctors use body-mass index (BMI) as an indicator of a decline in health related to treatment. The team compared how well BMI and SMI predicted poor outcomes, such as earlier death or the need of a feeding tube. They found that SMI was a better predictor of poor outcomes, potentially making it a more valuable clinical tool.

"BMI is an imperfect measure," says Kann. "It doesn't tell you anything about fat content or muscle content, which are really the components we need to be measuring in the clinic."

An AI-based assessment of sarcopenia could be made frequently throughout treatment, giving physicians a chance to recognize a patient's decline before it reaches a critical point. That could trigger an intervention, such as a nutritional consult, supportive medication, or physical therapy.

"If we see muscle mass begin to decline, we can do something to prevent it," says Kann.

The tool could also be used to guide treatment decisions up front. For instance, a patient who already has when diagnosed with cancer might fare better with gentler treatment than someone who is more physically robust.

For next steps, Kann and colleagues plan to apply the tool to scans throughout the course of treatment for patients in a clinical trial setting. They hope to learn more about how muscle mass changes during treatment and to learn how to use the information to guide treatments and interventions.

More information: Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck Cancer, JAMA Network Open (2023).

Journal information: JAMA Network Open

Citation: AI-driven muscle mass assessment could improve care for head and neck cancer patients (2023, August 10) retrieved 7 December 2023 from https://medicalxpress.com/news/2023-08-ai-driven-muscle-mass-neck-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

AI algorithm may help better guide oropharynx cancer treatment

31 shares

Feedback to editors